The Victorian Comprehensive Cancer Centre (VCCC) is a purpose built centre of excellence, delivered as a Public Private Partnership (PPP) under the Government’s Partnerships Victoria framework. This world class facility has been specifically designed to support translational research, education and comprehensive cancer care and is located within the prestigious Melbourne Biomedical Precinct in Parkville. The building brings together a network of partners including Peter MacCallum Cancer Centre, Melbourne Health and University of Melbourne to form the VCCC Alliance. This “network” is reflected in the spiralling forms expressed across the façade of the building, and also in the organically formed atrium within. The brief was to make an iconic statement and attract the best cancer clinicians and researchers from across the world.
The facility is designed to deliver maximum seamless care and research and provides 90,000m2 across 13 floor above ground and 4 basement levels for carparking, services and radiotherapy. The VCCC extends its connections across to the Royal Melbourne Hospital campus, with 3 bridge links connecting patients, services and staff across Grattan Street. This reinforces the precinct and fosters collaborations and connection.
The clinical component across both buildings includes 160 overnight beds (72% single), with a 42 bed intensive care unit, 110 chemotherapy places, 24 bed clinical trials unit, country patient accommodation and 8 radiotherapy bunkers. An education floor sits in the middle of the main VCCC building and provides world class education and training facilities.
1200 researchers occupy the wet research floors from levels 7-12. Dry research is located on the lower floors, embedded within the clinical components to foster interaction amongst researchers and clinicians.
The interiors provide a calming, reassuring palette with use of Victorian timbers in key locations such as patient lifts, and receptions as a wayfinding cue. Magenta has been used to identify receptions and waiting areas. There are seven landscaped roof gardens for patients, public and researchers embedded through the building, maximising connection to nature, and the views of the surrounding cityscape.
STH, in association with Design Inc (STHDI) and MCR Architects designed, planned and delivered this facility as part of the Plenary Health consortium.
VCCC has won numerous awards, culminating with the Victorian Medal at the AIA 2018 Awards.
PROJECT SIZE: 90,000 m²
STATUS: Completed 2016
CLIENT: Plenary Health VHHSBA (Victorian Health and Human Services Building Authority)
PHOTOGRAPHY: Peter Bennetts
STH (Silver Thomas Hanley), are a recognised national and international architecture healthcare design practice.
The practice commenced in 1978 with founding directors Peter and Aija Thomas. Today STH has over 100 specialist healthcare design staff and have completed over 2000 healthcare projects. There are eight directors that lead the practice and work collaboratively on each project with Principals, Associates and Project Architects.
STH specialise in Health and Sciences Architecture. Our portfolio includes Acute Tertiary Hospitals, Private Hospitals, Residential Aged Care, Teaching, Training and Research Facilities, and Institutional work.
We have been successful in PPP commissions and competitions nationally and internationally, and won national architectural awards for our three most recently completed PPP Hospitals. STH are the only Australian EDAC Advocate Firm, and take pride in our quality, delivery, capacity and intuitive innovative approach to each commission.
STH provide the full spectrum of architectural services to their clients. This includes Master Planning and Feasibility Studies, Proof of Concepts, Clinical Health Planning, Architectural Design, Contract Documentation and Administration and Interior Design. We use leading 3D visualisation and BIM as design and documentation tools.
STH maintain corporate offices in Melbourne, Sydney and Adelaide. We also undertake commissions with associated offices in Canada, Singapore, Hong Kong, Malaysia and Indonesia.